Suppr超能文献

肿瘤抑制因子Smad4/DPC 4作为Smad功能的核心介质。

The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.

作者信息

Zhang Y, Musci T, Derynck R

机构信息

Department of Growth and Development, University of California at San Francisco, San Francisco, California 94143-0640, USA.

出版信息

Curr Biol. 1997 Apr 1;7(4):270-6. doi: 10.1016/s0960-9822(06)00123-0.

Abstract

BACKGROUND

The invertebrate and vertebrate Smad proteins have recently been identified as important mediators of the responses to transforming growth factor beta (TGF-beta) and related factors. We have previously shown that Smad3 and Smad4 (the product of the tumor suppressor gene DPC 4) strongly synergize as mediators of TGF-beta signaling, and that inactive carboxy-terminally truncated mutants of either Smad act as dominant-negative inhibitors of the natural TGF-beta response. The finding that Smad4, unlike Smad3, does not interact with the TGF-beta receptor, coupled with the distinct structural features of Smad4, raises the possibility that Smad4 cooperates not only with Smad3, but also with Smad1 and Smad2 to mediate signaling by TGF-beta family members.

RESULTS

Overexpression of Smad4 in 'animal caps' taken from Xenopus embryos induced both ventral and dorsal mesoderm, thereby mimicking the effects of TGF-beta family members - bone morphogenetic protein-2 (BMP-2) or BMP-4 and activin, respectively. Low levels of Smad4 mRNA coinjected with Smad1 or Smad2 mRNA also synergized to induce ventral or dorsal mesoderm, respectively. In addition, Smad4 synergized Smad2, as it does with Smad3, to induce gene expression from the promoter for plasminogen activator inhibitor-1. The carboxy-terminal domains of both Smad3 and Smad4 were required for this synergy. Finally, a short carboxy-terminal truncation of Smad4, previously identified as a mutation of DPC 4 in tumors, blocked nuclear translocation of wild-type Smads 1, 2, 3 and 4, consistent with our observation of a physical interaction between truncated Smad4 and the other Smads.

CONCLUSIONS

Our observations indicate that Smad4 cooperates with Smad1, Smad2 and Smad3 to act as a common mediator of signaling by TGF-beta-related factors, and provide a mechanism that explains the dominant-negative interference with receptor signaling that results from expression of the naturally occurring Smad4/DPC 4 truncation mutant.

摘要

背景

无脊椎动物和脊椎动物的Smad蛋白最近被确定为转化生长因子β(TGF-β)及相关因子反应的重要介质。我们之前已经表明,Smad3和Smad4(肿瘤抑制基因DPC 4的产物)作为TGF-β信号传导的介质具有强烈的协同作用,并且任一Smad的无活性羧基末端截短突变体作为天然TGF-β反应的显性负性抑制剂。与Smad3不同,Smad4不与TGF-β受体相互作用这一发现,以及Smad4独特的结构特征,增加了Smad4不仅与Smad3合作,还与Smad1和Smad2合作以介导TGF-β家族成员信号传导的可能性。

结果

在取自非洲爪蟾胚胎的“动物帽”中过表达Smad4可诱导腹侧和背侧中胚层,从而分别模拟TGF-β家族成员——骨形态发生蛋白-2(BMP-2)或BMP-4以及激活素的作用。与Smad1或Smad2 mRNA共注射的低水平Smad4 mRNA也分别协同诱导腹侧或背侧中胚层。此外,Smad4与Smad2协同作用,就像它与Smad3协同作用一样,诱导纤溶酶原激活物抑制剂-1启动子的基因表达。这种协同作用需要Smad3和Smad4的羧基末端结构域。最后,先前在肿瘤中鉴定为DPC 4突变的Smad4的短羧基末端截短阻断了野生型Smads 1、2、3和4的核转位,这与我们观察到的截短的Smad4与其他Smads之间的物理相互作用一致。

结论

我们的观察结果表明,Smad4与Smad1、Smad2和Smad3合作,作为TGF-β相关因子信号传导的共同介质,并提供了一种机制,解释了天然存在的Smad4/DPC 4截短突变体表达导致的对受体信号传导的显性负性干扰。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验